Murine Cell Line Models for Vascular Mimicry: The Role of YAP/TAZ Signaling

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment

Background:

• Vascular mimicry (VM) involves tumor cells forming vessel-like structures, linked to aggressive cancers and poor prognosis.
• Current VM research predominantly uses melanoma models; human cell lines in mouse models lack organ-specific microenvironments.
• Murine cell lines offer a viable alternative for studying VM in syngeneic models, crucial for understanding tumor vascularization.

Purpose of the Study:

• To establish and characterize murine colorectal (CT26) and pancreatic cancer (KPC) cell lines as models for studying vascular mimicry (VM).
• To investigate the in vitro mechanisms regulating VM in these murine cancer models, including environmental factors and signaling pathways.
• To assess the therapeutic potential of targeting YAP/TAZ signaling in VM-driven cancers.

Main Methods:

• In vitro cell-based assays were used to confirm VM formation in CT26 and KPC cell lines.
• Cells were subjected to serum deprivation and hypoxia to evaluate their impact on VM.
• YAP/TAZ signaling was inhibited using small molecule inhibitors (e.g., CA3) and validated with dual YAP/TAZ knockdown.
• Cell proliferation, apoptosis, and cell cycle changes were analyzed post-inhibition.

Main Results:

• CT26 and KPC cells demonstrated intrinsic VM formation, enhanced by serum deprivation and hypoxia.
• YAP/TAZ signaling inhibition significantly attenuated VM formation and reduced cell proliferation.
• The inhibitor CA3 induced apoptosis in CT26 cells and altered cell cycle progression in both cell lines.
• Dual YAP/TAZ knockdown confirmed the critical role of this pathway in abrogating VM.

Conclusions:

• CT26 and KPC murine cell lines are suitable models for investigating vascular mimicry (VM).
• YAP/TAZ signaling is a key regulator of VM in these colorectal and pancreatic cancer models.
• Targeting YAP/TAZ signaling presents a potential therapeutic strategy for cancers exhibiting VM.